Medical Developments International Limited
MVP
Rank in Stocks
#24215
Medical Developments International Limited (MDIL) specializes in the... Medical Developments International Limited (MDIL) specializes in the development and provision of essential emergency medical solutions, serving global markets including Australia, Europe, and the United States. The company's operations are divided into two primary segments: Pain Management and Respiratory care. Among its key offerings is Penthrox, a product specifically formulated for rapid pain relief in acute trauma and emergency situations. Within the respiratory segment, MDIL supplies equipment designed to assist individuals with conditions like asthma and chronic obstructive pulmonary disease (COPD). Additionally, its comprehensive portfolio features a diverse array of medical devices, encompassing items such as CPR face shields and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, oxygen resuscitation kits, and various oxygen therapy and resuscitation apparatus. Established in 2003, the company maintains its headquarters in Scoresby, Australia.
Share Price
$0.30802456
Last synced: 2026-11-10
Market Cap
$34.70M
Change (1 day)
7.23%
Change (1 year)
-15.87%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Medical Developments International Limited (MVP)
Category
Healthcare
Operating Margin for Medical Developments International Limited (MVP)
Operating Margin as of November 2026 TTM: 2.48%
According to Medical Developments International Limited's latest financial reports, its current operating margin (TTM) is 2.48%. At the end of 2025 the company had an operating margin of 7.87%.
Operating Margin history for Medical Developments International Limited from 2003 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 2.48% | -68.49% |
| 2025 | 7.87% | -115.47% |
| 2024 | -50.88% | -19.52% |
| 2023 | -63.22% | -11.62% |
| 2022 | -71.53% | 245.06% |
| 2021 | -20.73% | -349.46% |
| 2020 | 8.31% | -45.33% |
| 2019 | 15.20% | 28.27% |
| 2018 | 11.85% | -37.89% |
| 2017 | 19.08% | -16.97% |
| 2016 | 22.98% | -9.03% |
| 2015 | 25.26% | 38.41% |
| 2014 | 18.25% | -43.32% |
| 2013 | 32.20% | 14.22% |
| 2012 | 28.19% | 52.79% |
| 2011 | 18.45% | 77.40% |
| 2010 | 10.40% | 26.52% |
| 2009 | 8.22% | -16.89% |
| 2008 | 9.89% | -51.71% |
| 2007 | 20.48% | 27.76% |
| 2006 | 16.03% | -909.60% |
| 2005 | -1.98% | -113.78% |
| 2004 | 14.37% | -84.66% |
| 2003 | 93.66% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -92.17% |
DE
|
|
| 19.68% | -92.06% |
DE
|
|
| 13.26% | -94.65% |
JP
|
|
| 17.08% | -93.11% |
CH
|
|
| 14.92% | -93.98% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Medical Developments International Limited's operating margin
What is Medical Developments International Limited's operating margin?
Medical Developments International Limited's operating margin is 2.48%, as of Nov 2026.
What was Medical Developments International Limited's operating margin in 2025?
In 2025, Medical Developments International Limited's operating margin was 7.87%, compared with -50.88% in 2024.
How has Medical Developments International Limited's operating margin changed since 2020?
From 2020 to 2025, Medical Developments International Limited's operating margin was highest in 2020 (8.31%) and lowest in 2022 (-71.53%).
How does Medical Developments International Limited's operating margin compare with similar companies?
Medical Developments International Limited's operating margin (2.48%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.